Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Olopatadine recalled?

Yes — there is an active recall. 10 ongoing FDA recalls mention Olopatadine (13 total). Check the affected lots below.

Most common reason: cGMP deviation (5 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Olopatadine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Olopatadine recalls on record

none so far in 2026; 13 on record, newest first
Class II · Moderate risk

Clear Eyes

Failed Impurities Specification: Out-of-specification (OOS) stability test result was obtained for unspecified impurity.

Terminated Impurity / degradation Teva Pharmaceuticals USA Inc NDC 67172-504-01 D-0469-2023
Class II · Moderate risk

Pataday

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 0065-8150-01 D-1321-2022